Press Releases
March 23, 2020
Researchers at the GW Cancer Center published a new knowledgebase and web portal, OncoMX, which will improve the exploration and research of cancer biomarkers in the context of related evidence.
January 14, 2020
WASHINGTON (January 22, 2020) - The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
September 24, 2019
WASHINGTON (Sept. 24, 2019) - PTEN, a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B, to function.
August 20, 2019
WASHINGTON (Aug. 16, 2019) - The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center.
August 2, 2019
Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University (GW) Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
July 30, 2019
Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University (GW) and the GW Cancer Center today announced that Carla J. Berg, PhD, MBA, has been named the associate center director for population sciences and policy for the GW Cancer Center. Berg, who starts…
July 24, 2019
A research team led by Yanfen Hu, PhD, professor of anatomy and cell biology at the George Washington University (GW) School of Medicine and Health Sciences and member of the GW Cancer Center, is studying the role of the tumor suppressor BRCA1 in the homologous recombination pathway of DNA double-…
July 9, 2019
Sun safety practices for attendees at skin cancer screening events differ from the general public, according to findings published by researchers from the George Washington University (GW) Cancer Center. The study was published in the Journal of Drugs in Dermatology.
May 13, 2019
The George Washington University (GW) Cancer Center is pleased to announce the establishment of the Dr. Cyrus Katzen Family Director of the GW Cancer Center, thanks to a generous gift from GW alumnus and former Board of Trustee member, Jay Katzen, BA ’67, MD ’72.
April 22, 2019
In the last 25 years, significant progress has been made in the fight against cancer. Even still, cancer remains the second most common cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention - and those in the D.C. area are not immune to its burden.